Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23829485 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab

Indicates status has not been verified in more than two years